The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

48 citing papers in PubMed.

1. Profiling of proteases involved in SARS-CoV-2 pathogenesis in human saliva: Influence of age and gender.Journal, genetic engineering & biotechnology · 2025
   Article
2. Research Advances on Swine Acute Diarrhea Syndrome Coronavirus.Animals : an open access journal from MDPI · 2024
   Review
3. Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC.Frontiers in cellular neuroscience · 2024
   Article
4. Mucosal immunity in upper and lower respiratory tract to MERS-CoV.Frontiers in immunology · 2024
   Review
5. Astrocytes Are a Key Target for Neurotropic Viral Infection.Cells · 2023
   Review
6. Screening compounds for treating the diabetes and COVID-19 from Miao medicine by molecular docking and bioinformatics.Arabian journal of chemistry · 2023
   Article
7. Fast and accurate genome-wide predictions and structural modeling of protein-protein interactions using Galaxy.BMC bioinformatics · 2023
   Article
8. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons.mBio · 2022
   Article
9. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia.World journal of diabetes · 2022
   Article
10. Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic.Primary care diabetes · 2022
    Article
11. Multivalent ACE2 engineering-A promising pathway for advanced coronavirus nanomedicine development.Nano today · 2022
    Review
12. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology.Biomedicines · 2022
    Review
13. In SARS-CoV-2, astrocytes are in it for the long haul.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
14. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.BMC cancer · 2022
    Article
15. Limited extent and consequences of pancreatic SARS-CoV-2 infection.Cell reports · 2022
    Article
16. Hematopoietic responses to SARS-CoV-2 infection.Cellular and molecular life sciences : CMLS · 2022
    Review
17. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.Clinics and research in hepatology and gastroenterology · 2022
    Review
18. Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern.Trends in immunology · 2022
    Article
19. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.Viruses · 2022
    Article
20. SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry.Frontiers in immunology · 2022
    Review

Corrections and comments

• Erratum for
  The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.2020

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.